Ofatumumab Dose-finding in Relapsing Remitting Multiple Sclerosis (RRMS) Patients

Clinical trial NCT00640328 · COMPLETED

Trial details

NCT number: NCT00640328
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Sclerosis

Start date: 2008-05-01
Primary completion: 2010-05-01
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.